'Global fragility' is adding to the pressure on forwarders
As high-value, temperature-sensitive cargo, pharmaceutical shipments can be complex and it is crucial to meet ...
DSV: 'AHEAD IN BIDDING FOR SCHENKER'DSV: UNLUCKY FRIDAYSMAERSK: WEAK AGAINWMT: NEW PARTNERSHIPXPO: HAMMEREDKNIN: LEGAL FIGHTF: UPDATEMAERSK: CROSS-BORDER BOOST MAERSK: NIGERIA TERMINAL EXPANSION FDX: 'NON-EVENT' CORPORATE STRUCTURE UPDATE XPO: WINNERS AND LOSERS ODFL: 'SOFTNESS'
DSV: 'AHEAD IN BIDDING FOR SCHENKER'DSV: UNLUCKY FRIDAYSMAERSK: WEAK AGAINWMT: NEW PARTNERSHIPXPO: HAMMEREDKNIN: LEGAL FIGHTF: UPDATEMAERSK: CROSS-BORDER BOOST MAERSK: NIGERIA TERMINAL EXPANSION FDX: 'NON-EVENT' CORPORATE STRUCTURE UPDATE XPO: WINNERS AND LOSERS ODFL: 'SOFTNESS'
Hot on the heels of tying up a joint-venture with Maersk to introduce more blockchain activity to the container shipping sector, IBM has come together with Chinese supply chain firm Hejia to run a blockchain trial for the pharmaceuticals supply chain, and particularly address China’s “underdeveloped credit evaluation system”, which, it argues, “can make it difficult to raise short-term capital”. What this means in practice is that smaller retailers which supply drugs to Chinese hospitals will get paid quicker, thus accelerating the velocity of a supply chain in which speed can mean the difference between life and death.
Comment on this article